A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors. Available at: https://clinicaltrials.gov/ct2/show/NCT03067181.

View in Article Google ScholarNigam M. Aschebrook-Kilfoy B. Shikanov S. et al.

Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009.

World J Urol. 2015; 33: 623-631View in Article Google ScholarGhazarian A.A. McGlynn K.A.

Increasing incidence of testicular germ cell tumors among racial/ethnic minorities in the United States.

Cancer Epidemiol Biomarkers Prev. 2020; 29: 1237-1245View in Article Google ScholarStephenson A. Eggener S.E. Bass E.B. et al.

Diagnosis and treatment of early stage testicular cancer: AUA guideline.

J Urol. 2019; 202: 272-281View in Article Google ScholarHonecker F. Aparicio J. Berney D. et al.

ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up.

Ann Oncol. 2018; 29: 1658-1686View in Article Google ScholarMead G.M.

International germ cell consensus classification: a prognostic factor- based staging system for metastatic germ cell cancers.

J Clin Oncol. 1997; 15: 594-603View in Article Google ScholarGillessen S. Sauvé N. Collette L. et al.

Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium.

J Clin Oncol. 2021; 39: 1563-1574View in Article Google ScholarBeyer J. Collette L. Sauvé N. et al.

Survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium.

J Clin Oncol. 2021; 39: 1553-1562View in Article Google ScholarLobo J. Leão R. Jerónimo C. et al.

Liquid biopsies in the clinical management of germ cell tumor patients: State-of-the-art and future directions.

Int J Mol Sci. 2021; 22: 1-22View in Article Google ScholarWein Alan J. Kavoussi Louis R. Partin Alan W. et al.

Campbell-walsh urology.

10th ed. Elsevier Saunders, Philadelphia, PA2016View in Article Google ScholarJavadpour N.

The role of biologic tumor markers in testicular cancer.

Cancer. 1980; 45: 1755-1761View in Article Google ScholarLange P.H. Winfield H.N.

Biological markers in urologic cancer.

Cancer. 1987; 60: 464-472View in Article Google ScholarMilose J.C. Filson C.P. Weizer A.Z. et al.

Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance.

Open Access J Urol. 2011; 4: 1-8View in Article Google ScholarTalerman A. Haije W.G. Baggerman L.

Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: Value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).

Int J Cancer. 1977; 19: 741-746View in Article Google ScholarSyring I. Bartels J. Holdenrieder S. et al.

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer.

J Urol. 2015; 193: 331-337View in Article Google ScholarWymer K.M. Daneshmand S. Pierorazio P.M. et al.

Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatment.

Ann Oncol. 2017; 28: 899-902View in Article Google ScholarDieckmann K.P. Radtke A. Spiekermann M. et al.

Serum Levels of MicroRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours.

Eur Urol. 2017; 71: 213-220View in Article Google ScholarStenman U.H. Alfthan H. Hotakainen K.

Human chorionic gonadotropin in cancer.

Clin Biochem. 2004; 37: 549-561View in Article Google ScholarGerma J.R. Arcusa A. Casamitjana R.

False elevations of human chorionic gonadotropin associated to latrogenic hypogonadism in gonadal germ cell tumors.

Cancer. 1987; 60: 2489-2493View in Article Google ScholarCatalona W.J. Vaitukaitis J.L. Fair W.R.

Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: Conversion to negative with testosterone administration.

J Urol. 1979; 122: 126-128View in Article Google ScholarGarnick M.B.

Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer.

N Engl J Med. 1980; 303: 1177View in Article Google ScholarHarclerode J.

Endocrine effects of marijuana in the male: preclinical studies.

NIDA Res Monogr. 1984; 44: 46-64View in Article Google ScholarBraunstein G.D. Thompson R. Gross S. et al.

Marijuana use does not spuriously elevate serum human chorionic gonadotropin levels.

Urology. 1985; 25: 605-606View in Article Google ScholarVon Eyben F.E. Blaabjerg O. Petersen P.H. et al.

Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor.

J Urol. 1988; 140: 986-989View in Article Google ScholarToner G.C. Geller N.L. Tan C. et al.

Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.

Cancer Res. 1990; 50: 5904-5910View in Article Google ScholarSoares D.G. Millot F. Lacroix I. et al.

Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient.

Urol Case Reports. 2016; 9: 1-3View in Article Google ScholarBolstad N. Warren D.J. Nustad K.

Heterophilic antibody interference in immunometric assays.

Best Pract Res Clin Endocrinol Metab. 2013; 27: 647-661View in Article Google ScholarMurray M.J. Halsall D.J. Hook C.E. et al.

Identification of microRNAs From the miR-371∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.

Am J Clin Pathol. 2011; 135: 119-125View in Article Google ScholarNappi L. Thi M. Lum A. et al.

Developing a highly specific biomarker for germ cell malignancies: Plasma MiR371 expression across the germ cell malignancy spectrum.

J Clin Oncol. 2019; 37: 3090-3098View in Article Google ScholarVoorhoeve P.M. le Sage C. Schrier M. et al.

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Adv Exp Med Biol. 2007; 604: 17-46View in Article Google ScholarLafin J.T. Singla N. Woldu S.L. et al.

Serum MicroRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-naïve patients undergoing retroperitoneal lymph node dissection.

Eur Urol. 2020; 77: 290-292View in Article Google ScholarLeão R. van Agthoven T. Figueiredo A. et al.

Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor.

J Urol. 2018; 200: 126-135View in Article Google ScholarMego M. van Agthoven T. Gronesova P. et al.

Clinical utility of plasma miR-371a-3p in germ cell tumors.

J Cell Mol Med. 2019; 23: 1128-1136View in Article Google ScholarAbol-Enein H. Ghoneim M.A.

Functional results of orthotopic ileal neobladder with serous-lined extramural ureteral reimplantation: experience with 450 patients.

J Urol. 2001; 165: 1427-1432View in Article Google Scholarvan Agthoven T. Looijenga L.H.J.

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

Oncotarget. 2017; 8: 58037-58049View in Article Google ScholarDieckmann K.P. Spiekermann M. Balks T. et al.

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.

Br J Cancer. 2012; 107: 1754-1760View in Article Google ScholarDieckmann K.P. Radtke A. Geczi L. et al.

Serum Levels of MicroRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell tumors: Results of a prospective multicentric study.

J Clin Oncol. 2019; 37: 1412-1423View in Article Google ScholarShen H. Shih J. Hollern D.P. et al.

Integrated molecular characterization of testicular germ cell tumors.

Cell Rep. 2018; 23: 3392-3406View in Article Google ScholarLobo J. van Zogchel L.M.J. Nuru M.G. et al.

Combining hypermethylated rassf1a detection using ddpcr with mir-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients.

Cancers (Basel). 2021; 13: 1-15View in Article Google ScholarChovanec M. Albany C. Mego M. et al.

Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice.

Front Oncol. 2018; 8: 1-7View in Article Google ScholarNappi L. Thi M. Adra N. et al.

Integrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumors.

Eur Urol. 2021; 79: 16-19View in Article Google ScholarBelge G. Grobelny F. Radtke A. et al.

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin.

J Cancer Res Clin Oncol. 2021; 147: 435-443View in Article Google ScholarAgathanggelou A. Cooper W.N. Latif F.

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.

Cancer Res. 2005; 65: 3497-3508View in Article Google Scholar

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors. Available at: https://clinicaltrials.gov/ct2/show/NCT03067181.

View in Article Google Scholar

NCT04435756. A Study of miRNA 371 in Patients With Germ Cell Tumors.

(Available at:)https://clinicaltrials.gov/ct2/show/NCT04435756View in Article Google ScholarEllinger J. Wittkamp V. Albers P. et al.

Cell-Free Circulating DNA: diagnostic value in patients with testicular germ cell cancer.

J Urol. 2009; 181: 363-371View in Article Google ScholarAfrifa J. Zhao T. Yu J.

Circulating mitochondria DNA, a non-invasive cancer diagnostic biomarker candidate.

Mitochondrion. 2019; 47: 238-243View in Article Google ScholarEllinger J. Albers P. Müller S.C. et al.

Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.

BJU Int. 2009; 104: 48-52View in Article Google ScholarYang C. Xia B.R. Jin W.L. et al.

Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model.

Cancer Cell Int. 2019; 19: 1-13View in Article Google ScholarHildebrandt M. Bläser F. Beyer J. et al.

Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques.

Bone Marrow Transpl. 1998; 22: 771-775View in Article Google ScholarYuasa T. Yoshiki T. Tanaka T. et al.

Detection of circulating testicular cancer cells in peripheral blood.

Cancer Lett. 1999; 143: 57-62View in Article Google ScholarHautkappe A.L. Lu M. Mueller H. et al.

Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.

Cancer Res. 2000; 60: 3170-3174View in Article Google ScholarNastały P. Honecker F. Pantel K. et al.

Detection of circulating tumor cells (CTCs) in patients with testicular germ cell tumors.

Methods Mol Biol. 2021; 2195: 245-261View in Article Google Scholar